% | $
Quotes you view appear here for quick access.

Facebook, Inc. (FB) Message Board

  • bobbaylinson bobbaylinson Dec 7, 2012 10:29 AM Flag

    Seeking "SRPT 62 Week data out, MEANS EARLY APPROVAL" link

    Seeking Alpha
    Biotech Stocks With Important Catalysts Approaching
    December 7, 2012
    Sarepta will announced 62 week clinical data confirming the 48 week data and seek accelerated approval from the FDA for eteplirsen. The release of the 62 week data could occur anytime and, if positive, would certainly propel the stock and give Sarepta more leverage for accelerated approval from the FDA.

102.01+0.10(+0.10%)Feb 12 4:00 PMEST